Every jurisdiction defines who may place a used aesthetic laser on the market differently, and the question that changes everything is simple to state and hard to answer: after you import, refurbish, or relabel the device, who is the manufacturer? In some markets the answer turns a used-equipment seller into a regulated manufacturer with obligations far beyond customs paperwork; in others the importer or sponsor carries the registration burden. This guide maps the questions and the official sources for the United States, the European Union, the United Kingdom, Canada, and Australia. It is a compliance map and source guide, not legal advice — verify every line with counsel and the authorities before you ship.

Why jurisdiction matters for used devices

A used device is still a medical device in the eyes of every regulator listed here, and “used” does not create an exemption. What varies is the trigger: whether the device needs a premarket authorization or registration, whether the person importing or selling it must hold a licence or sponsor status, and whether refurbishing activities make you a manufacturer. The same transaction can be lawful in one country and non-compliant in another, so the compliance path must be built per destination before contracts are signed.

United States: FDA registration, 510(k), and importing

In the United States, a device must meet the FDA’s applicable premarket and establishment requirements before commercial distribution. For many aesthetic lasers, the premarket path is a 510(k) clearance — the FDA’s searchable database lets you look up the device name and number (for example, records such as K193446 for an 808 nm diode hair-removal laser or K212607 for a modular workstation). Separate from clearance, the parties who manufacture, repackage, relabel, or import the device are generally subject to establishment registration and device listing under 21 CFR Part 807, and initial importers have their own obligations. Questions to answer before import:

• Does the specific model and configuration have a clearance or classification that covers its intended use?
• Who registers and lists — the foreign manufacturer, the importer, or both?
• Does the product also fall under FDA’s radiation-emitting electronic product requirements, which use declaration form FDA 2877 at import (CBP Form 2877 information)?
• What supporting records (affirmation of compliance, product reports where required) must travel with the shipment?

Refurbishing used devices in the US can shift obligations: significant changes to a cleared device may require a new or supplemental premarket submission, and the refurbisher’s role must be analyzed against FDA guidance. Confirm with FDA-specific counsel before promising “refurbished and cleared” in marketing.

European Union: MDR and the refurbisher trigger

Under Regulation (EU) 2017/745 (the MDR), obligations attach to manufacturers, importers, distributors, and in defined situations to parties who substantially change a device or place it on the market under their own name. The MDR’s definitions and obligations (Articles 2 and 10–16) are the starting text; the European Commission’s MDCG-endorsed guidance documents explain how those rules are applied in practice (MDCG guidance portal). The question a used-device seller must answer before the first listing:

• Are you selling an existing, CE-marked device without changing it (distributor-type activity in most analyses), or are you repairing, reconditioning, or relabeling it in a way that makes you the manufacturer or refurbisher?
• If the original CE marking no longer covers the device’s state, who holds the conformity assessment responsibility?
• Who is the importer into the EU Member State, and what registration and vigilance obligations follow?

This is the area where informal “we clean and test it” language creates the most risk: cleaning and testing are not the same as the regulatory status changes that trigger manufacturer obligations. Get a written analysis before describing a unit as MDR-compliant.

United Kingdom: UKCA transition

Since the end of the transition period, medical devices placed on the Great Britain market have been subject to UK rules, and the marking regime has been evolving through the UKCA transition and CE-recognition policy changes announced by the MHRA. The authoritative starting point is GOV.UK’s medical-devices regulation guidance (regulating medical devices in the UK), which covers registration, marking, and the responsible-person concept. Because the transition dates and recognition rules have changed over time, do not rely on a cached summary: check the current guidance and any MHRA consultation responses on the date you plan to place devices on the market, and confirm whether the device is intended for Great Britain, Northern Ireland, or both, since the applicable regimes differ.

Canada and Australia paths

Canada regulates devices through the Food and Drugs Act and Medical Devices Regulations, with licensing of devices (Classes II–IV) and establishment licensing for importers and distributors. Health Canada’s medical-device establishment licensing guidance (GUI-0016) explains who must hold an MDEL and the obligations that follow; a revised edition takes effect December 14, 2026, so verify which edition applies on your transaction date (GUI-0016). Australia takes a sponsor-based approach: an Australian entity must normally be the sponsor, hold responsibility for the device, and secure inclusion in the ARTG before the device is imported and supplied. TGA’s own SME-assist case studies walk through exactly the situation a used-device buyer faces — importing without a sponsor role is a compliance failure, not a paperwork shortcut (TGA case studies).

Document checklist

Before any cross-border used-device transaction, assemble:

1. Device identity: manufacturer, model, serial, and original intended use.
2. Original market authorization or clearance records (510(k), CE/MDR, ARTG, or equivalent) with dates.
3. The full chain of ownership since manufacture, including any refurbishment work and by whom.
4. Service and maintenance records naming the serial.
5. Your status analysis for the destination market: manufacturer, importer, distributor, sponsor, or refurbisher.
6. Shipping, customs, and radiation-declaration forms required by the destination (such as FDA Form 2877 where it applies).
7. A named regulatory counsel or qualified expert review of the status analysis before signing.

When to engage counsel

Engage qualified counsel before you sign anything if any of these is true: you plan to refurbish, relabel, or recondition; you are selling under your own brand; the device’s original authorization is expired, regional, or unclear; or the transaction crosses more than one of the five jurisdictions above. The cost of a written opinion is a fraction of the cost of a non-compliant shipment — and unlike the shipment, the opinion can be reused across transactions.

Use the official sources above as your reference shelf, and treat every summary — including this guide — as a map to be re-read against the current text on your transaction date. Equipment sourcing inquiries and direct contact with the ALLWILL team can connect you with documented inventory and documentation practices, but the compliance decision for your market stays with you and your counsel — no seller’s brochure can make that determination for you.